Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > On the bright side

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon Mar 14, 2024 4:00pm

91 Views

Post# 35933463

RE:RE:RE:On the bright side

Considering financial statements, known revanue and grants over the years I think that anti-aging costs represent between 15-20 million CAD (20-26 million USD). It's hard to tell exactly because the anti-aging part has not been specified.

Anyone that wants to join Sirona Laboratories and earn 49 percent must contribute with almost the same amount that Sirona Biochem has spent on the compound. That alone would increase current company value with 100 percent if reflected as share price.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario